Friday, 29 March 2024
Checkpoint Therapeutics Inc.
05:39 | 2/1/18
Voice Of Analysts
The Andersons, Inc. (ANDE) is sinking -2.35% to $31.15. The stock's short float is around of 2.20% and short ratio is 4.84.
more»
18:26 | 1/1/18
Concord Register
Checkpoint Therapeutics, Inc. (:CKPT) closed at $3.46 after seeing 77106 shares trade hands during the most recent session.
more»
01:33 | 11/12/17
The Ledger Gazette
Checkpoint Therapeutics earned a news sentiment score of 0.09 on Accern's scale. Accern also assigned news articles about the company an impact score of 45.1845271112077 out of 100, indicating that recent news coverage is somewhat unlikely to have an ...
more»
04:00 | 10/12/17
Rives Journal
Checkpoint Therapeutics, Inc. (:CKPT) shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm.
more»
06:48 | 9/12/17
BZ Weekly
It's the latest price, but let's analyze how the stock has been doing recently. In the past year, Checkpoint Therapeutics Inc Co's stock was big mover. According to the short interest report published recently, (CKPT) had 100 shorted shares for 1.0 ...
more»
"The selection of validated targets helps to reduce the development time and risk of the asset, in our belief," the analyst said.
more»
10:56 | 23/11/17
BZ Weekly
The stock of Checkpoint Therapeutics Inc (NASDAQ:CKPT) reached all time low today, Nov, 23 and still has $3.63 target or 8.00 % below today's $3.95 share price.
more»
02:18 | 1/10/17
Melville Review
Checking in on some valuation rankings, Red Lion Hotels Corporation (NYSE:RLH) has a Value Composite score of 48. Developed by James O'Shaughnessy, the VC score uses five valuation ratios.
more»
03:45 | 22/9/17
Seeking Alpha
This is where Mirati Therapeutics comes in with its cancer drug sitravatinib. It can combine its ... The target market of those who don't respond to checkpoint inhibitor therapy are 43,000 patients in the United States alone (company slides page 24 ...
more»
00:22 | 12/9/17
GlobeNewswire
NEW YORK, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that the U.S.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |